An innovative approach uses a biocompatible material to encapsulate probiotic bacteria and combines them with antibiotics to tackle treatment-resistant infections.
Every year, over 2 million people in the United States develop infections that are resistant to treatment, and approximately 23,000 people die as a result.
These statistics have prompted the Centers for Disease Control and Prevention (CDC) to deem drug resistance “one of the biggest public health challenges of our time.”
Therefore, researchers are hard at work trying to develop ingenious ways of tackling so-called superbugs — bacteria that have become immune to antibiotic treatment.
Lately, researchers have added probiotics to their arsenal against superbugs. Probiotics are beneficial bacteria found in foods, such as yogurt, kefir, pickles, or miso soup.
Only a month ago, for example, a study suggested that simply consuming probiotics on a regular basis could reduce the need for antibiotics, thus helping to curb the drug resistance crisis.
Now, researchers used probiotics to create a “killer” combination that destroyed two strains of treatment-resistant bacteria.
The two co-senior and corresponding authors of the study are Ana Jaklenec, a research scientist at the Koch Institute for Integrative Cancer Research at the Massachusetts Institute of Technology in Cambridge, MA, and Robert Langer, the David H. Koch Institute Professor at MIT.
Zhihao Li is the first author of the paper, now published in the journal Advanced Materials.
The study’s first author explains the problem of tackling antibiotic resistant infections with probiotics.
On the one hand, he says, probiotics have been somewhat successful at tackling bacteria when applied to wounds. However, probiotics are usually not enough to destroy all of the bacteria found in a wound infection.
On the other hand, Li says, adding antibiotic to the mix would kill too many bacteria, including the beneficial probiotics.
So, Li and colleagues set out to find a workaround by enclosing the probiotics in a shell that protects them from being destroyed by the antibiotic. They chose a material called alginate to design the shell.
Alginate stood out to the researchers as a good choice for two main reasons. Firstly, it is a component of the biofilm that bacteria naturally form when they are trying to shield themselves from antibiotics. Secondly, doctors already use the component in the treatment of wounds.
“We looked into the molecular components of biofilms, and we found that for Pseudomonas infection, alginate is very important for its resistance against antibiotics,” Li says. “However, so far no one has used this ability to protect good bacteria from antibiotics.”
For their study, Li and colleagues chose a probiotic made up of three strains of Lactobacillus bacteria — a type of bacteria that can kill off methicillin-resistant Staphylococcus aureus (MRSA).
The researchers combined the probiotics with the antibiotic tobramycin, which is known to kill Pseudomonas aeruginosa (P. aeruginosa).
Then, Li and colleagues applied the alginate-coated probiotics together with tobramycin to MRSA and P. aeruginosa in a petri dish. The combination “completely eradicated” the treatment-resistant bacteria, according to Jaklenec.
“It was quite a drastic effect,” adds the co-senior author. By contrast, when the researchers recreated the experiment without the alginate coating, the antibiotics killed the probiotics, which in turn spared the MRSA bacteria.
“When we just used one component, either antibiotics or probiotics, they couldn’t eradicate all the pathogens,” Li reports. “That’s something, which can be very important in clinical settings where you have wounds with different bacteria, and antibiotics are not enough to kill all the bacteria.”
The researchers are hopeful that their approach will tackle the drug-resistance crisis, and plan to test it in animals and humans.
“There are so many bacteria now that are resistant to antibiotics, which is a serious problem for human health. We think one way to treat them is by encapsulating a live probiotic and letting it do its job,” says Jaklenec.
“The good thing about alginate is it’s [U.S. Food and Drug Administration]-approved, and the probiotic we use is approved as well,” Li adds.
“I think probiotics can be something that may revolutionize wound treatment in the future. With our work, we have expanded the application possibilities of probiotics.”